Treatment Efficacy and Safety of Tenofovir Alafenamide (TAF) Switch Therapy in Patients Who Have Been Treated With Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B: a Real Life Multicenter Cohort Study in Korea
Phase of Trial: Phase IV
Latest Information Update: 06 Feb 2019
Price : $35 *
At a glance
- Drugs Tenofovir alafenamide (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 29 Jan 2019 Status changed from not yet recruiting to recruiting.
- 17 Jul 2018 Planned initiation date changed from 1 Jun 2018 to 18 Jul 2018.
- 26 Jun 2018 New trial record